Op Ed article submitted to the New York Times on December 8, 2000.
The Medicine You Never Knew
by Chris Duffield Ph.D.
Visiting Scholar, Stanford University, and webhost
ph 650- fx 413-702-9849
POBox 19652, Stanford CA 94309-9652
On Thanksgiving Day, while you were feasting and thinking about the
election, a great doctor, Donato Perez Garcia y Bellon, MD,
("Donato 2") died in his home in Mexico City, at age 70,
quietly, unexpectedly, in obscurity. While tragic for his family, his
wife, and two young children, this was an even bigger tragedy for the
world. You never heard of him, but he was a living treasure of
humanity. You never knew that billions of people could benefit from
the knowledge that he passed on, and that millions could suffer for
lack of the details we let him die with.
On that day, I was chatting by computer with his son, Donato Perez
Garcia, MD ("Donato 3"), when he got the phone call from his
fatherís wife, crying. The shocking message appeared on my screen:
his father, weak from a three-day illness, was no longer breathing.
"No!!", I prayed quietly, "please donít let this
But it did.
You never knew that Donato 2 was the master of insulin potentiation
therapy (IPT), a medical procedure that his father Donato Perez
Garcia, MD ("Donato 1") discovered in 1926. IPT is a
non-diabetic use of the hormone insulin to induce a brief pulse of
mild hypoglycemia (low blood sugar), which somehow boosts
effectiveness of regular drugs, transports them better into cells and
parts of the body that are normally inaccessible, and has other
beneficial effects. IPT is not a magic bullet, but a magic gun. In
IPT, normal drugs act like super drugs, in smaller doses, with reduced
toxicity. 75 years after its discovery, IPT is still a radical new
idea. I call it "the second discovery of insulin".
You never knew that, with IPT, many cancers have been treated
without surgery or radiation, getting better and faster results, and
often complete remissions, using regular chemotherapy drugs in 1/10
the normal dose, and with no side effects. Breast cancer, prostate
cancer, lung cancer, and even pancreatic cancer and melanoma have been
treated without surgery or side effects, using this simple
modification of chemotherapy.
You never knew that, with IPT, arthritis symptoms have routinely
gone away after only two or three treatments, with relief lasting five
to seven years.
You never knew that, with IPT, antibiotics and antiviral drugs
become so effective and are so well delivered into cells, and into
sequestered tissues like the brain, that infectious diseases have
responded with unprecedented rapidity and completeness. Complete
remissions of herpes, hepatitis C, and HIV/AIDS have been obtained.
Perhaps IPT could offer better treatment of other infectious scourges
in both rich and poor countries: malaria; tuberculosis; Lyme disease;
mycobacteria in lungs; and hidden infections that may be the real
cause of heart disease, mental illness, multiple sclerosis, Alzheimerís
disease, and obesity. IPT may also be an answer to the emerging peril
of multiple drug resistance.
You never knew that, with IPT and penicillin, Donato 1 was able to
completely heal ulcers non-surgically in the late 1940s, 47 years
before general recognition that they are caused by H. pylori
infection. Antibiotic treatment for ulcers became standard in 1997; it
might work better and faster with IPT. With IPT, Donato 1 was even
able to completely heal pyloric stenosis (ulcer-caused stricture of
the stomachís exit), for which surgery is still the only standard
treatment. He was ahead of his time, and even ahead of our time.
You never knew that with IPT, Donato 1 and Donato 2 were able to
quickly reverse the paralysis of polio in children in the 1950s. (This
could come in handy if polio returns.) And you never knew that another
IPT doctor reported incredibly rapid reversal of stroke paralysis.
Could IPT be a simple and inexpensive way to medically proliferate
stem cells in the nervous system, perhaps a part of the cure for
spinal cord injuries that Christopher Reeve is seeking?
You never knew that, with IPT, remarkable rapid results have also
been reported in treatment of respiratory and cardiovascular diseases.
IPT appears to offer better patient outcomes, faster, safer, at lower
cost, over a broad spectrum of human illnesses.
You never knew. But why? Because, despite the efforts of Donato 1,
Donato 2, and the three doctors he taught, no one has listened. They
published books and papers reporting their results. Donato 1 toured
the US several times, even appearing in Time Magazine in 1944, like a
time traveler from the 21st century whose message was lost
in the tumult of World War II. Donato 2 toured the world and
corresponded with doctors, researchers, and drug companies, to no
avail. Jean-Claude Paquette, in Quebec, was censured by his peers.
SGA, MD, a Chicago area physician, has published numerous
papers about IPT, some with Donatos 2 and 3. The IPT doctors have
presented their best cancer cases to the National Institutes of Health
(NIH) twice, in 1997 and on September 18 this year, but so far without
tangible response. Nothing.
I have been involved with IPT for 14 years, and have experienced
similar difficulties first hand. In my efforts to help get IPT
researched and adopted, and to get the Drs. Perez Garcia invited to
the US to teach and practice, I have approached many people and
organizations about IPT. And I have been rejected, ignored, sometimes
sneered at, by billionaires, millionaires, foundations, government and
university officials, researchers, doctors, and drug companies.
If they respond at all, it is usually with the same 15 or 20
arguments: if it were real, I would have heard about it by now (not
necessarily); if it were real, someone else would have done something
with it (they havenít); there are no controlled clinical studies
cited (no, because they havenít been done or funded yet); it is not
credible because it works for too many different things (is that a
problem?); giving insulin to non-diabetics might be dangerous (not in
135 doctor-years of safe IPT experience); it could be just a placebo
(unlikely, but if so itís a great one, worth studying); it is
"too far out of the box", and "coming from left
field" (so what, if it works?); you canít trust medicine coming
from Mexico (nonsense!); and so forth.
If and when IPT is validated, it will confirm that a 75-year
holocaust of omission has been going on. Unnecessary surgery and
radiation treatments, unnecessarily toxic chemotherapy treatments
(hair loss, nausea, immune compromise), slow and ineffective treatment
of arthritis and infectious diseases, and more. Unimaginable suffering
and death, often at the hands of well-meaning physicians, one patient
at a time. Every one of us, among our families and friends, has
sustained tremendous losses in this hidden holocaust.
You never knew about IPT because all of us involved with IPT have
run into pervasive arrogance, skepticism, and both types of ignorance
(passive, from lack of exposure, and active, from turning away) among
doctors, researchers, and people in high places. It appears that the
people we count on to search the world for things like IPT, study
them, and make them available, have let us down. Drug companies have
shunned IPT, perhaps because lower drug doses with IPT could disrupt
their markets. The mammoth NIH has so far done nothing about IPT,
either scientifically or clinically. These huge organizations have
brought us many wonderful things. But IPT, with its great promise, has
fallen completely through their filters, for three generations. This
is our tragic loss.
That is why I am turning to the private sector, seeking the right
philanthropists to lead a broad nonprofit initiative to turn the tide
for IPT research and implementation.
IPT, invented in 1926 and ignored for 75 years, could become a
cornerstone of 21st century medicine. Fortunately, the core
of Donato 2ís IPT knowledge has been preserved, enough for us to
eventually reconstruct or rediscover the details that he took with him
in death. The IPT knowledge he left now resides in his papers (I have
put many of them on a large IPT website, IPTQ.org), and in the minds
and practices of Donato 3 and the eight doctors (five in the US) that
he has trained. Today, while we still wait for IPT research to begin,
any doctor can learn IPT in a three-day seminar with Donato 3, and can
legally practice this simple technique now, since it is merely an
unlabeled use of existing approved drugs.
You never knew about IPT, and now its master, Donato 2, is gone.
How many other great medical discoveries have been similarly ignored
or lost? How can we avoid other tragic delays and hidden holocausts
like this one? How can we ensure that all avenues are explored to
bring the best of medicine to the people of this world?
Chris Duffield PhD is webhost of IPTQ.org, and a Visiting Scholar
at Stanford University. Copyright